Table 3 Adverse events experienced by patients receiving adjuvant TS-1 treatment
Events | Patients, n = 40 (%) | ||||
|---|---|---|---|---|---|
Grade I | Grade II | Grade III | Grade IV | Total | |
Skin pigmentation | 18 (45) | 4 (10) | 0 | 0 | 22 (55) |
Diarrhea | 1 (2.5) | 7 (17.5) | 2 (5) | 1 (2.5) | 11 (27.5) |
Fatigue | 1 (2.5) | 2 (5) | 0 | 0 | 3 (7.5) |
Vomiting | 3 (7.5) | 2 (5) | 1 (2.5) | 0 | 6 (15) |
Stomatitis | 0 | 2 (5) | 3 (7.5) | 0 | 5 (12.5) |
Anorexia | 5 (12.5) | 1 (2.5) | 1 (2.5) | 0 | 7 (17.5) |
Alopecia | 3 (7.5) | 0 | 0 | 0 | 3 (7.5) |
Dizziness | 8 (20) | 2 (5) | 1 (2.5) | 0 | 11 (27.5) |
Leukopenia | 1 (2.5) | 5 (12.5) | 2 (5) | 0 | 8 (20) |
Thrombocytopenia | 2 (5) | 0 | 0 | 0 | 2 (5) |
Anemia | 1 (2.5) | 4 (10) | 0 | 0 | 5 (12.5) |